Homocysteine and Hyperhomocysteinaemia.
Zaric BL, Obradovic M, Bajic V, Haidara MA, Jovanovic M, Isenovic ER.
Curr Med Chem. 2019;26(16):2948-2961. doi: 10.2174/0929867325666180313105949.
Homocysteine metabolism.
Selhub J.
Annu Rev Nutr. 1999;19:217-46. doi: 10.1146/annurev.nutr.19.1.217.
Inherited disorders of sulfur amino acid metabolism: recent advances in therapy.
Kožich V, Majtan T.
Curr Opin Clin Nutr Metab Care. 2021 Jan;24(1):62-70. doi: 10.1097/MCO.0000000000000705.
Inborn errors of amino acid metabolism - from underlying pathophysiology to therapeutic advances.
Ziegler SG, Kim J, Ehmsen JT, Vernon HJ.
Dis Model Mech. 2023 Nov 1;16(11):dmm050233. doi: 10.1242/dmm.050233. Epub 2023 Nov 23.
Hyperhomocysteinaemia.
Perry DJ.
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):451-77. doi: 10.1053/beha.1999.0036.
3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.
Grünert SC, Stucki M, Morscher RJ, Suormala T, Bürer C, Burda P, Christensen E, Ficicioglu C, Herwig J, Kölker S, Möslinger D, Pasquini E, Santer R, Schwab KO, Wilcken B, Fowler B, Yue WW, Baumgartner MR.
Orphanet J Rare Dis. 2012 May 29;7:31. doi: 10.1186/1750-1172-7-31.
Monoamine neurotransmitter deficiencies.
Pearl PL.
Handb Clin Neurol. 2013;113:1819-25. doi: 10.1016/B978-0-444-59565-2.00051-4.
Homocystinuria.
Przyrembel H.
Ergeb Inn Med Kinderheilkd. 1982;49:77-135. doi: 10.1007/978-3-642-68543-9_2.
Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria.
Majtan T, Kožich V, Kruger WD.
Br J Pharmacol. 2023 Feb;180(3):264-278. doi: 10.1111/bph.15991. Epub 2022 Dec 8.
B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis.
Du X, Ma X, Tan Y, Shao F, Li C, Zhao Y, Miao Y, Han L, Dang G, Song Y, Yang D, Deng Z, Wang Y, Jiang C, Kong W, Feng J, Wang X.
Signal Transduct Target Ther. 2023 Mar 13;8(1):103. doi: 10.1038/s41392-023-01313-x.
